Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy

Kidney International

Volumn 82, Issue 12, 2012, Pages 1304-1312

  Oh, Hyung Jung ^a   Ahn, Song Vogue ^b   Yoo, Dong Eun ^a   Kim, Seung Jun ^a   Shin, Dong Ho ^a   Lee, Mi Jung ^a   Kim, Hyoung Rae ^a   Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Han, Seung Hyeok ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

clinical outcomes; HSP nephritis; IgA nephropathy

Indexed keywords

CREATININE; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HENOCH SCHONLEIN PURPURA NEPHRITIS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VASCULITIS;

EID: 84870582400     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.302     Document Type: Article

References (33)

1. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192.
2. Ravelli A, Carnevale-Maffe G, Ruperto N et al. IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. Nephron 1996; 72: 111-112.
3. Knight JF. The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schonlein purpura. Pediatr Nephrol 1990; 4: 533-541.
4. Meadow SR, Scott DG. Berger disease: Henoch-Schonlein syndrome without the rash. J Pediatr 1985; 106: 27-32.
5. Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 2001; 59: 823-834.
6. Rauta V, Teppo AM, Tornroth T et al. Lower urinary-interleukin-1 receptorantagonist excretion in IgA nephropathy than in Henoch-Schonlein nephritis. Nephrol Dial Transplant 2003; 18: 1785-1791.
7. D'Amico G, di Belgiojoso GB, Imbasciati E et al. Idiopathic IgA mesangial nephropathy: natural history. Contrib Nephrol 1984; 40: 208-213.
8. Coppo R, Mazzucco G, Cagnoli L et al. Long-term prognosis of Henoch- Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant 1997; 12: 2277-2283.
9. Sinniah R, Feng PH, Chen BT. Henoch-Schoenlein syndrome: a clinical and morphological study of renal biopsies. Clin Nephrol 1978; 9: 219-228.
10. Shrestha S, Sumingan N, Tan J et al. Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM 2006; 99: 253-265.
11. Pillebout E, Thervet E, Hill G et al. Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002; 13: 1271-1278.
12. Allen AC, Willis FR, Beattie TJ et al. Abnormal IgA glycosylation in Henoch- Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13: 930-934.
13. Lau KK, Wyatt RJ, Moldoveanu Z et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 2007; 22: 2067-2072.
14. Novak J, Moldoveanu Z, Renfrow MB et al. IgA nephropathy and Henoch- Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 2007; 157: 134-138.
15. Haas M. IgA nephropathy and Henoch-Schonlein purpura. In: Jennette JC, Olson JL, Schwartz MM et al. (eds). Pathology of the Kidney, 6th edn. Lippincott Williams & Wilkins: Philadelphia, 2007, pp 423-486.
16. Davin JC. Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 2011; 6: 679-689.
17. Floege J. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis 2011; 58: 992-1004.
18. Kiryluk K, Moldoveanu Z, Sanders JT et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Kidney Int 2011; 80: 79-87.
19. Coppo R, Andrulli S, Amore A et al. Predictors of outcome in Henoch- Schonlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003.
20. Hwang HS, Kim BS, Shin YS et al. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Nephrology (Carlton) 2010; 15: 236-241.
21. Reich HN, Troyanov S, Scholey JW et al. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007; 18: 3177-3183.
22. Floege J, Eitner F. Current therapy for IgA nephropathy. J Am Soc Nephrol 2011; 22: 1785-1794.
23. Tarshish P, Bernstein J, Edelmann Jr CM. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004; 19: 51-56.
24. Pillebout E, Alberti C, Guillevin L et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura. Kidney Int 2010; 78: 495-502.
25. Hurley RM, Drummond KN. Anaphylactoid purpura nephritis: clinicopathological correlations. J Pediatr 1972; 81: 904-911.
26. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications. AMA J Dis Child 1960; 99: 833-854.
27. Derham RJ. Prognosis of Henoch-Schonlein nephritis in children. Br Med J 1977; 2: 262.
28. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842.
29. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
30. Remuzzi A, Perticucci E, Ruggenenti P et al. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991; 39: 1267-1273.
31. Maschio G, Cagnoli L, Claroni F et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 1994; 9: 265-269.
32. Pozzi C, Andrulli S, Del Vecchio L et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163.
33. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 2010; 172: 1092-1097.